Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer

Journal of Virology

Volumn 82, Issue 19, 2008, Pages 9329-9336

  Contreras Galindo, Rafael ^a   Kaplan, Mark H ^a   Leissner, Philippe ^c   Verjat, Thibault ^c   Ferlenghi, Ilaria ^d   Bagnoli, Fabio ^d   Giusti, Fabiola ^e   Dosik, Michael H ^f   Hayes, Daniel F ^a,b   Gitlin, Scott D ^a,g   Markovitz, David M ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^c BIOMÉRIEUX   (France)

^d NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^e UNIVERSITY OF SIENA   (Italy)

^f N Shore Hematol/Oncol Associates   (United States)

^g VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ENVELOPE PROTEIN; FOSCARNET; GAG PROTEIN; METHOTREXATE; PREDNISONE; RITUXIMAB; RNA DIRECTED DNA POLYMERASE; VINBLASTINE SULFATE; VINCRISTINE; VIRUS RNA;

ARTICLE; B CELL LYMPHOMA; BLOOD LEVEL; BLOOD SAMPLING; BREAST CANCER; BURKITT LYMPHOMA; CANCER CHEMOTHERAPY; CONTROLLED STUDY; ENDOGENOUS RETROVIRUS; HODGKIN DISEASE; HUMAN; HUMAN ENDOGENOUS RETROVIRUS K; IMMUNOELECTRON MICROSCOPY; LYMPHOMA; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NUCLEIC ACID SEQUENCE BASED AMPLIFICATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS LOAD; VIRUS PARTICLE;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CONTRAST MEDIA; ENDOGENOUS RETROVIRUSES; HUMANS; LYMPHOMA; MICROSCOPY, IMMUNOELECTRON; REMISSION INDUCTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC; TRIIODOBENZOIC ACIDS;

HUMAN ENDOGENOUS RETROVIRUS K;

EID: 52649113832     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00646-08     Document Type: Article

References (60)

1. Armbruester, V., M. Sauter, E. Krautkraemer, E. Meese, A. Kleiman, B. Best, K. Roemer, and N. Mueller-Lantzsch. 2002. A novel gene from the human endogenous retrovirus K expressed in transformed cells. Clin. Cancer Res. 8:1800-1807.
2. Armbruester, V., M. Sauter, K. Roemer, B. Best, S. Hahn, A. Nty, A. Schmid, S. Philipp, A. Mueller, and N. Mueller-Lantzsch. 2004. Np9 protein of human endogenous retrovirus K interacts with ligand of numb protein X. J. Virol. 78:10310-10319.
3. Bannert, N., and R. Kurth. 2004. Retroelements and the human genome: new perspectives on an old relation. Proc. Natl. Acad. Sci. USA 101:14572-14579.
4. Barbulescu, M., G. Turner, M. Seaman, A. Deinard, K. Kidd, and J. Lenz. 1999. Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. Curr. Biol. 9:861-868.
5. Beimforde, N., K. Hanke, I. Ammar, R. Kurth, and N. Bannert. 2008. Molecular cloning and functional characterization of the human endogenous retrovirus K113. Virology 371:216-225.
6. Belancio, V. P., D. J. Hedges, and P. Deininger. 2008. Mammalian non-LTR retrotransposons: for better or worse, in sickness and in health. Genome Res. 18:343-358.
7. Belshaw, R., A. L. A. Dawson, J. Woolven-Allen, J. Redding, A. Burt, and M. Tristem. 2005. Genomewide screening reveals high levels of insertional polymorphism in the human endogenous retrovirus family HERV-K(HML2): implications for present-day activity. J. Virol. 79:12507-12514.
8. Belshaw, R., V. Pereira, A. Katzourakis, G. Talbot, J. Paces, A. Burt, and M. Tristem. 2004. Long-term reinfection of the human genome by endogenous retroviruses. Proc. Natl. Acad. Sci. USA 101:4894-4899.
9. Bhadra, S., M. M. Lozano, and J. P. Dudley. 2005. Conversion of mouse mammary tumor virus to a lymphomagenic virus. J. Virol. 79:12592-12596.
10. Bieda, K., A. Hoffmann, and K. Boller. 2001. Phenotypic heterogeneity of human endogenous retrovirus particles produced by teratocarcinoma cell lines. J. Gen. Virol. 82:591-596.
11. Boese, A., M. Sauter, U. Galli, B. Best, H. Herbst, J. Mayer, E. Kremmer, K. Roemer, and N. Mueller-Lantzsch. 2000. Human endogenous retrovirus protein cORF supports cell transformation and associated with the promyelocytic leukemia zinc finger protein. Oncogene 19:4328-4336.
12. Boller, K., H. Konig, M. Sauter, N. Mueller-Lantzsch, R. Löwer, J. Löwer, and R. Kurth. 1993. Evidence that HERV-K is the endogenous retrovirus sequence that codes for the human teratocarcinoma-derived retrovirus HTDV. Virology 196:349-353.
13. Boller, K., K. Schönfeld, S. Lischer, N. Fischer, A. Hoffmann, R. Kurth, and R. R. Tönjes. 2008. Human endogenous retrovirus HERV-K113 is capable of producing intact viral particles. J. Gen. Virol. 89:567-572.
14. Burmeister, T., A. D. Ebert, W. Pritze, C. Loddenkemper, S. Schwartz, and E. Thiel. 2004. Insertional polymorphisms of endogenous HERV-K113 and HERV-K115 retroviruses in breast cancer patients and age-matched controls. AIDS Res. Hum. Retroviruses 20:1223-1229.
15. Büscher, K., S. Hahn, M. Hofmann, U. Trefzer, M. Ozel, W. Sterry, J. Löwer, R. Löwer, R. Kurth, and J. Denner. 2006. Expression of the human endogenous retrovirus-K transmembrane envelope, Rec and Np9 proteins in melanoma cell lines. Melanoma Res. 16:223-234.
16. Büscher, K., U. Trefzer, M. Hofmann, W. Sterry, R. Kurth, and J. Denner. 2005. Expression of human endogenous retrovirus K in melanomas and melanoma cell lines. Cancer Res. 65:4172-4180.
17. Caliendo, A. M., J. Ingersoll, A. M. Fox-Canale, S. Pargman, T. Bythwood, M. K. Hayden, J. W. Bremer, and N. S. Lurain. 2007. Evaluation of real-time PCR laboratory-developed tests using analyte-specific reagents for cytomegalovirus quantification. J. Clin. Microbiol. 45:1723-1727.
18. Contreras-Galindo, R., M. Gonzalez, S. Almodovar, S. Gonzalez-Ramirez, E. Lorenzo, and Y. Yamamura. 2006. A new real-time-RT-PCR for quantitation of human endogenous retroviruses type K (HERV-K) RNA load in plasma samples: increased HERV-K RNA titers in HIV-1 patients with HAART non-suppressive regimens. J. Virol. Methods 136:51-57.
19. Contreras-Galindo, R., M. H. Kaplan, D. M. Markovitz, E. Lorenzo, and Y. Yamamura. 2006. Detection of HERV-K (HML-2) viral RNA in plasma of HIV type 1-infected individuals. AIDS Res. Hum. Retroviruses 22:979-984.
20. Denne, M., M. Sauter, V. Armbruester, J. D. Licht, K. Roemer, and N. Mueller-Lantzsch. 2007. Physical and functional interactions of human endogenous retrovirus proteins Np9 and rec with the promyelocytic leukemia zinc finger protein. J. Virol. 81:5607-5616.
21. Depil, S., C. Roche, P. Dussart, and L. Prin. 2002. Expression of a human endogenous retrovirus, HERV-K, in the blood cells of leukemia patients. Leukemia 16:254-2:59.
22. Dewannieux, M., S. Blaise, and T. Heidmann. 2005. Identification of a functional envelope protein from the HERV-K family of human endogenous retroviruses. J. Virol. 79:15573-15577.
23. Dewannieux, M., F. Harper, A. Richaud, C. Letzelter, D. Ribet, G. Pierron, and T. Heidmann. 2006. Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements. Genome Res. 16:1548-1556.
24. Ejthadi, H. D., J. H. Martin, J. Junying, D. A. Roden, M. Lahiri, P. Warren, P. G. Murray, and P. N. Nelson. 2005. A novel multiplex RT-PCR system detects human endogenous retrovirus-K in breast cancer. Arch. Virol. 150:177-184.
25. Galli, U. M., M. Sauter, B. Lecher, S. Maurer, H. Herbst, K. Roemer, and N. Mueller-Lantzsch. 2005. Human endogenous retrovirus rec interferes with germ cell development in mice and may cause carcinoma in situ, the predecessor lesion of germ cell tumors. Oncogene 24:3223-3228.
26. Garrison, K. E., R. B. Jones, D. A. Meiklejohn, N. Anwar, L. C. Ndhlovu, J. M. Chapman, A. L. Erickson, A. Agrawal, G. Spotts, F. M. Hecht, S. Rakoff-Nahoum, J. Lenz, M. A. Ostrowski, and D. F. Nixon. 2007. T cell responses to human endogenous retroviruses in HIV-1 infection. PloS Pathog. 3:e165.
27. Giacona, M. B., G. C. Ruben, K. A. Iczkowski, T. B. Roos, D. M. Porter, and G. D. Sorenson. 1998. Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls. Pancreas 17:89-97.
28. Jahr, S., H. Hentze, S. Englisch, D. Hardt, F. O. Fackelmayer, R. D. Hesch, and R. Knippers. 2001. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 61:1659-1665.
29. Johnston, J., C. Silva, J. Holden, K. Warren, A. Clark, and C. Power. 2001. Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases. Ann. Neurol. 50:434-442.
30. Kaito, M., S. Watanabe, K. Tsukiyama-Kohara, K. Yamaguchi, Y. Kobayashi, M. Konishi, M. Yokoi, S. Ishida, S. Suzuki, and M. Kohara. 1994. Hepatitis C virus particle detected by immunoelectron microscopic study. J. Gen. Virol. 75:1755-1760.
31. Kigami, D., N. Minami, H. Takayama, and H. Imai. 2003. MuERV-L is one of the earliest transcribed genes in mouse one-cell embryos. Biol. Reprod. 68:651-654.
32. Laderoute, M. P., A. Giulivi, L. Larocque, D. Bellfoy, Y. Hou, H. X. Wu, K. Fowke, J. Wu, and F. Mitoma. 2007. The replicative activity of human endogenous retrovirus K102 (HERV-K102) with HIV viremia. AIDS 21:2417-2424.
33. Lander, E. S., R. H. Waterston, J. Sulston, and F. S. Collins. 2001. Initial sequencing and analysis of the human genome. Nature 409:860-921.
34. Lee, Y., and P. D. Bieneasz. 2007. Reconstitution of an infectious human endogenous retrovirus. PLoS Pathog. 3:e10.
35. Löwer, R., J. Löwer, and R. Kurth. 1996. The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc. Natl. Acad. Sci. USA 93:5177-5184.
36. Löwer, R., K. Boller, B. Hasenmaier, C. Korbmacher, N. Mueller-Lantzsch, J. Löwer, and R. Kurth. 1993. Identification of human endogenous retroviruses with complex mRNA expression and particle formation. Proc. Natl. Acad. Sci. USA 90:4480-4484.
37. Matsuzawa, A., H. Nakano, Y. Yoshimoto, and K. Sayama. 1995. Biology of mouse mammary tumor virus (MMTV). Cancer Lett. 90:3-11.
38. Mayer, J., S. Ehlhardt, M. Seifert, M. Sauter, N. Mueller-Lantzsch, Y. Mehraein, K. D. Zang, and E. Meese. 2004. 2004. Human endogenous retrovirus HERV-K(HML-2) proviruses with Rec protein coding capacity and transcriptional activity. Virology 322:190-198.
39. Morgan, D., and I. Brodsky. 2004. Human endogenous retrovirus (HERV-K) particles in megakaryocytes cultured from essential thrombocythemia peripheral blood stem cells. Exp. Hematol. 32:520-525.
40. Moyes, D., A. Martin, S. Sawcer, N. Temperton, J. Worthington, D. Griffiths, and P. Venables. 2005. The distribution of the endogenous retroviruses HERV-K113 and HERV-K115 in health and disease. Genomics 86:337-341.
41. Moyes, D., D. J. Griffiths, and P. J. Venables. 2007. Insertional polymorphisms: a new lease of life for endogenous retroviruses in human disease. Trends Genet. 23:326-333.
42. Muster, T., A. Waltenberger, A. Grassauer, S. Hirschl, P. Caucig, I. Romirer, D. Födinger, H. Seppele, O. Schanab, C. Magin-Lachmann, R. Löwer, B. Jansen, H. Pehamberger, and K. Wolff. 2003. An endogenous retrovirus derived from human melanoma cells. Cancer Res. 63:8735-8741.
43. Nelson, P., P. Carnegie, J. Martin, E. Davari, P. Hooley, D. Roden, S. Rowland-Jones, P. Warren, J. Astley, and P. Murray. 2003. Demystified human endogenous retroviruses. Mol. Pathol. 56:11-18.
44. Ono, M., T, Yasunaga, T. Miyata, and H. Ushikubo. 1986. Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome. J. Virol. 60:589-598.
45. Paces, J., A. Pavlicek, and V. Paces. 2002. HERVd: the Human Endogenous Retroviruses Database. Nucleic Acids Res. 30:205-206.
46. Ribet, D., S. Louvet-Vallee, F. Harper, N. de Parseval, M. Dewannieux, O. Heidmann, G. Pierron, B. Maro, and T. Heidmann. 2008. Murine endogenous retrovirus MuERV-L is the progenitor of the "orphan" epsilon virus-like particles of the early mouse embryo. J. Virol. 82:1622-1625.
47. Ruda, V. M., S. B. Akopov, D. O. Trubetskoy, N. L. Manuylov, A. S. Vetchinova, L. L. Zavalova, L. G. Nikolaev, and E. D. Sverdlov. 2004. Tissue specificity of enhancer and promoter activities of a HERV-K(HML-2) LTR. Virus Res. 104:11-16.
48. Ryan, F. P. 2004. Human endogenous retroviruses in health and disease: a symbiotic perspective. J. R. Soc. Med. 97:560-565.
49. Seifarth, W., C. Baust, A. Murr, H. Skladny, F. Krieg-Schneider, J. Blusch, T. Werner, R. Hehlmann, and C. Leib-Mosch. 1998. Proviral structure, chromosomal location, and expression of HERV-K-T47D, a novel human endogenous retrovirus derived from T47D particles. J. Virol. 72:8384-8391.
50. Simpson, G. R., C. Patience, R. Löwer, R. R. Tönjes, H. D. Moore, R. A. Weiss, and M. T. Boyd. 1996. Endogenous D-type (HERV-K) related sequences are packaged into retroviral particles in the placenta and possess open reading frames for reverse transcriptase. Virology. 222:451-456.
51. Sugimoto, J., N. Matsuura, Y. Kinjo, N. Takasu, T. Oda, and Y. Jinno. 2001. Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. Genomics 72:137-144.
52. Tarlinton, R., J. Meers, and P. R. Young. 2006. Retroviral invasion of the koala genome. Nature 442:79-81.
53. Tarlinton, R., J. Meers, J. Hanger, and P. Young. 2005. Real-time reverse transcriptase PCR for the endogenous koala retrovirus reveals an association between plasma viral load and neoplastic disease in koalas. J. Gen. Virol. 86:783-787.
54. Tönjes, R. R., R. Löwer, K. Boller, J. Denner, B. Hasenmaier, H. Kirsch, H. König, C. Korbmacher, C. Limbach, R. Lugert, R. C. Phelps, J. Scherer, K. Thelen, J. Löwer, and R. Kurth. 1996. HERV-K: the biologically most active human endogenous retrovirus family. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13(Suppl. 1):S261-S267.
55. Turner, G., M. Barbulescu, M. Su, M. Jensen-Seaman, K. Kidd, and J. Lenz. 2001. Insertional polymorphisms of full-length endogenous retroviruses in humans. Curr. Biol. 11:1531-1535.
56. Wang-Johanning, F., A. Frost, B. Jian, L. Epp, D. Lu, and G. Johanning. 2003. Quantitation of HERV-K env gene expression and splicing in human breast cancer. Oncogene 22:1528-1535.
57. Wang-Johanning, F., A. R. Frost, G. L. Johanning, M. B. Khazaeli, A. F. LoBuglio, D. R. Shaw, and T. V. Strong. 2001. Expression of human endogenous retrovirus K envelope transcripts in human breast cancer. Clin. Cancer Res. 7:1553-1560.
58. Yang, J., H. P. Bogerd, S. Peng, H. Wiegand, R. Truant, and B. R. Cullen. 1999. An ancient family of human endogenous retroviruses encodes a functional homolog of the HIV-1 Rev. protein. Proc. Natl. Acad. Sci. USA 96:13404-13408.
59. Yi, J. M., H. M. Kim, and H. S. Kim. 2001. Molecular cloning and phylogenetic analysis of the human endogenous retrovirus HERV-K long terminal repeat elements in various cancer cells. Mol. Cells 12:137-141.
60. Yotsuyanagi, Y., and D. Szollosi. 1980. Embryo development and intracisternal particles in the mouse. Biol. Cell 39:201-204.